Huang M, et al. - In women with ovarian cancer, researchers assessed the rate of germline and somatic testing as well as they determined the differences in testing at a comprehensive cancer center (CCC) and a safety net hospital (SNH). Of overall 367 women, 55.3% and 27.0% completed germline testing and received somatic testing, respectively. In comparison to women at the SNH, those at the CCC were more likely to receive germline and somatic testing. Less chances of receiving germline testing were reported for patients with Medicare or Medicaid vs those privately insured. Somatic testing was less likely to be received by patients with Medicaid vs those privately insured. A higher probability of being tested for germline and somatic mutations was reported in women with disease recurrence. Findings highlighted the existence of differences in both germline and somatic testing.